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Eukaryotic chemotactic signaling networks which regulate the cell’s ability to 
sense the gradient of chemotactic cues frequently have the dual property of perfect 
adaptation to spatially homogeneous inputs, and persistent activation by inputs that are 
spatially graded. This property is also shared by bacterial chemotaxis networks, raising 
the question of whether these two types of chemotactic processes also have similar 
organizations of the underlying biomolecular processes. Interestingly, perfect adaptation 
can only be achieved robustly through a handful of mechanisms. Eukaryotic chemotactic 
networks appear to rely on one of these—the incoherent feed-forward loop, while 
bacterial chemotaxis depends on another—the negative feedback loop. In this 
dissertation, we will discuss how this conclusion can be reached even if the details of the 
molecular networks are incompletely understood. Furthermore, we argue that the use of 
distinct network architectures is not accidental and may be a consequence of the nature of 
the signaling inputs and the limitations of the sensory properties of different cell types. 
Biological systems always appear as diverse and complicated. Not all the 
chemotaxis can be classified into the two categories we discussed above. For example, 
the beta-arrestin2, an important G-protein coupled receptor signaling mediator and 
scaffold, -mediated cell chemotaxis did not show perfect adaptation. We explored the 
mechanisms by both experimental and computational approaches and found that the beta-





prompts receptor desensitization to achieve non-perfect adaptation; 2) It assembles 
signaling complex to response to the input gradients; 3) It amplifies the external gradient 
by its unique scaffold biphasic regulation; 4) It organizes the receptor recycling to 
achieve persistent gradient sensing capacity; 5) It reorganizes the cytoskeleton during cell 
chemotaxis. Due to the biphasic regulation, the scaffold level is important in signal 
transduction. By manipulating the expression and distribution of the beta-arrestin2, we 
can convert chemoattractance to chemorepulsion or co-existence of both.  
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1.1 GPCRs and beta-arrestins 
G-Protein-Coupled Receptors (GPCRs) are the extremely important targets of 
therapeutically relevant drugs. They are encoded by more than 800 genes (about 4% of 
the human genome) and are targeted by 40% of all marketed drugs [1]. The large variety 
of stimuli ligands can range from small amines to hormones and chemokines [2], yet 
more and more synthetic ligands. Since their long track of success, GPCRs are sill the 
main targets for new drug research and development. Due to their highly conserved 
seven-transmembrane structure, they are also called 7TMRs [3].  
More importantly, the structural conservation provide extra conveniences for 
studying their functions and mechanisms [4]. Most current ligands to GPCR are thought 
to act via the “orthosteric” bundle binding sites in Family A (containing 80% of the 
GPCRs) receptors [5]. The conservation in structure of these receptors have been 
assessed base on a subset of 44 residues that are thought to form the majority of the 
binding sites [6]. Upon activation, the conformational changes of GPCRs act as a guanine 





changing its bound GDP for a GTP and dissociating it from the β and γ subunit. The 
activated α subunit in turh actives downstream signaling proteins depending the 
specificities. The two principal downstream signaling pathways of GPCRs are: the cAMP 
pathway and the phosphatidylinositol pathway [8]. The ligands activate the receptors are 
categorized as “agonist”, while the ligands block or dampen the agonist mediated 
responses are so called “antagonist”. 
After binding to agonist, the receptors not only trigger downstream signaling 
pathways, but also undergo modifications by other proteins. A significant family of 
kinase that modifies GPCRs is G protein-coupled receptor kinases (GRKs). GRKs 
phosphorylate serine and threonine residues to induce conformational changes and form 
binding sites for arrestins [9]. The arrestins’ binding to the receptors prevents the re-
association of the G-protein, and internalize the receptor from plasma membrane, thereby 
preventing the reactivation of downstream pathways. 
 Mammalian arrestin family has four members: arrestin-1 (also known as visual 
arrestin or S-antigen), beta-arrestin-1 (also known as arrestin-2), beta-arrestin-2 (also 
known as arrestin-3), and arrestin-4 (also known as the cone arrestin), and they are all  
cytosolic proteins [10]. The visual arrestin and cone arrestin are mostly found in visual 
system. They interact with upstream photoreceptors and downstream transducins to 
regulate the light sensitivity of eyes. In contrast, beta-arrestin1/2 are ubiquitously 
expressed. The word ‘ubiquitously’ means not only in all eukaryotic organisms, but also 
in virtually every eukaryotic cell. When initially discovered, beta-arrestins are thought to 





GPCRs which desensitize the GPCRs after being activated by ligands. After extensive 
studies, they are now known as crucial signaling mediators and molecular scaffolds [11].  
Beta-arrestins have a hugelong list of interaction partners by proteomic analysis 
[12-14]. They bind Src family non-receptor tyrosine kinases to activate dynamin and 
other Src downstream pathways. They associate AP2 and clathrin to from coated pits, 
together with dynamin, they contribute to the GPCR endocytosis. They interact with E3 
ubiquitin ligases, p53, and MDM2 to determine the endosome fate: whether it should go 
to lysosome or recycling. They bind cofilin, LIMK and filamin to change the 
cytoskeleton arrangement. They recognize NF-kB to regulate cell apoptosis and necrosis. 
They contribute to regulation of the calcium signaling through calmodulin. They also 
bind many multi-functional proteins like PI3K, small GTPase   family (Ras, Rho, Rac, 
Rab, Ral-GDS and ARF6), PDE4D and DGK [15]. In summary, the beta-arrestins 
function as signal transduction hub. 
Despite the fact that beta-arrestins play essential roles in GPCR signaling, it also 
involved in mass of other pathways like EGF receptor tyrosine kinases transactivation 
[16]. Even more, beta-arrestins are also work as molecular scaffolds. The molecular 
scaffold in signaling network is a protein that can assemble other signaling protein 
together to facilitate the signaling transduction. Beta-arrestin2 is a multi-pathway 
scaffold. It can assemble MAPK cascades like Raf-MEK-ERK, ASK1-MKK3-p38 and 
ASK1-MKK4-JNK3 for activation [17]. It can also coordinate PP2A-Akt-GSK3, 





transduction but also raise complex dynamic patterns which provide more ways for cells 
to control the spatial and temporal behaviors [19].  
Interestingly, beta-arrestins binding partners include themselves by forming either 
homo- or hetero- oligomers. The self-association feature of beta-arrestins are highly 
conserved in mammalian evolution [20]. The function of the oligomerization is still not 
very clear. But a few hypotheses are being tested: 1) It provides a mechanism to maintain 
physiological concentration of beta-arrestins monomers; 2) Hetero-mers help beta-
arrestins to regulate each other. 
Beta-arrestins also undergo complicated post-translational modifications. 
Phosphorylations of beta-arrestins at different sites can result in its inactivation or 
activation. Ubiquitination can decide the degradation or recycling of beta-arrestins. S-
Nitrosylation can strength the binding capacity of beta-arrestins. Recently, people even 
found that the GRKs can phosphorylate the different sites of receptors to alter the ligand-
dependent recruiting patterns of beta-arrestins. This novel finding is named as ‘barcode’.  
Beta-arrestins-mediated endosome is long lasting signaling platform. Taking 
Angiotensin II-actived ERK phosphorylation as an example: When activated, the G-
protein-mediated signaling is rapid and transient. It leads to nuclear translocation of 
activated ERK which can initiate the function of many transcription factors. On the other 
side, beta-arrestins-mediated ERK activation is slow but much greater persistent. In 
contrast, the activated ERK stably stays with the endosomes without going into the 
nuclear (Figure 1.1). The endosomes are involved in many other cytosolic protein 






Figure 1. 1 A) Beta-arrestin2 in charge of the long-term signaling of pERK, while G-protein 
mediated signaling is very transient. B) beta-arrestin2 mediated ERK activation 






It is surprising that the GPCR signaling can be so clearly separated into two 
branches (Figure 1.1 A): the G-protein dependent and beta-arrestin2 dependent. Such a 
distinct cut makes beta-arrestins the popular therapeutic targets for drug developments. A 
new era come into our sight: beta-arrestins-biased ligands shed light on the new idea of 
drug design. Conventional studies of GPCRs therapeutics discovered unavoidable side 
effects of targeting ligands, as distinct ligands are all cut through the same mechanism for 
a particular receptor [21]. Now, the researchers believe that, if we can find some drugs 
that only affect beta-arrestins side without disturbing the G-protein, we can provide much 




Chemotaxis is cells' or organisms' sensing and migrating to the gradient of a 
chemical stimulus gradient in the environment. This phenomenon happens at both single 
cell level and multicellular organism level, in eukaryotes as well as in prokaryotes, by 
spatial detection or temporal measurement. Bacteria approach food source or avoid 
poisons by chemotaxis. Immune systems chase infectious foreign organisms through 
chemotaxis. Cancer cells metastasizes by chemotaxis. Amoeba stands together to defend 
starvation using chemotaxis. In addition, chemotaxis is critical for the development in the 





Cell chemotaxis research is very important and hot for the several aspects: 1) It 
helps us to understand the biochemical process happened inside cell better. With non-
uniform environment, the cell displays imbalanced signal and molecule distribution in 
small scale. These polarizations lead us to explore the signaling transduction mechanisms 
that can not be observed under uniform treatment. 2) Almost all the information we 
gained from chemotaxis can be applied to other polarization behavior, including yeast 
shmooing, epithelial polarity or epithelial-mesenchymal transition, non-uniform 
development of organisms and even animal migration. 3) Clinically, chemotaxis study 
provides promising targets for preventing bacterial infections expanding, increasing 
immune system’s sensitivity, stopping cancer metastasis, and guiding correct 
development. 
Cell chemotaxis mechanisms have evolved to enable cell navigation in chemically 
and mechanically complex microenvironments, along with guidance by a range of 
signaling inputs reflecting spatially complicated extra- and intra-cellular conditions. 
Responsiveness to diverse cues permits individual cells to integrate diverse pieces of 
information and convert this information into the directionality of cell polarity and 
migration. This decision-making process is frequently complex, presenting interesting 
challenges to the experimentalists and modelers alike. Indeed, it is frequently hard to 
unravel complex intracellular signaling networks distributed in space and differentially 
activated in time, and it can be even harder to understand how activation of these 
networks can control both qualitative and quantitative characteristics of something still 
poorly understood, i.e. how cells define where their front and rear parts should be 





tools allowing simultaneous imposition of multiple extra-cellular cues, precisely 
controlled both in space and in time. The modelling approaches need to rely on the 
appropriate level of description of biological complexity, so that the model and 
experiment can inform each other, a notion that is still not quite rooted in the modelling 
community. 
Two model organisms are well built for studying chemotaxis: bacteria and 
Dictyostelium discoideum. The molecular mechanisms of chemotaxis of the two 
remarkably differ from each other. Bacteria sense gradient using so called “temporal 
sensing”: sensing the chemical gradient over time. Binding the chemoarrractants causes 
chemoreceptor clustering at cell poles. Chemoreceptors clusters link Che-W and Che-A , 
and form signaling complex. The complexes phosphorylate Che-B to Che-Bp and 
dephosphorylate Che-Yp to Che-Y. Che-Bp gives negatively feedback to disassemble the 
signaling complex. Che-Y is released to regulate flagellar motor rotation from clockwise 






Figure 1.2 Bacteria and Dictyostelium discoideum using different mechanisms to 
achieve chemotaxis: A) Bacteria using feedback and B) Dictyostelium 
using incoherent feed-forward loop. Figure is adapted from [24]. 
 
But the Dictyostelium discoideum senses gradient using “spatial sensing”. They 
can feel the concentration change along their body length. Their chemoreceptors are 
usually GPCRs. When activated, the G-protein signaling diverges into two branches: one 
through RasGEF and the other one through RasGAP. The two branches share the same 
downstream target Ras: RasGEF actives Ras while RasGAP inhibits Ras. This signaling 
motif is called incoherent feed-forward loop (Figure 1.2 B). 
Why different cells adapt different signaling motifs (feedback V.S. feed-






1.3 Cell chemotaxis and beta-arrestin2 
 
Both bacterial and Dictyostelium discoideum chemotaxis pathway can achieve full 
adaptation (Stimulated pathways can drop to base-line after a period). Presumably they 
can re-sense the updated concentration after moving to a new location of the gradients, so 
the signaling motifs that can achieve full adaptation are well studied and thought to be the 
basics of cell chemotaxis. However, as shown in Figure 1.1, the beta-arrestin2 signaling 
pathway does not fully adapt to the stimuli. Previous studies showed that beta-arrestin2 is 
involved in cell chemotaxis [25-27]. Moreover, they are critical in many GPCR mediated 
cell chemotaxis. 
Chemokines are the most well-known cell chemotaxis induction factors and all 
the chemokine receptors identified so far are GPCRs. Several lipids, hormones, and 
peptides also trigger the cell chemotactic behavior by binding to the GPCRs. Beta-
arrestins are required by a long list of chemokine receptor-mediated chemotaxis 
including: CXCR1 and 2, CXCR5, CCR2, CCR5 and CCR7. CXCR4 and 7 are general 
chemical cues used by many cells for chemotaxis: macrophages, T/B cells, neutrophils 
tumor cells, and germ cells. It is reported that the absence of beta-arrestin2 will impair 
the CXCR4-mediated chemotaxis. 
In addition to the chemokine receptors, beta-arrestins scaffolded MAPK 
activation is required by protease-activated receptor- [26, 27] and angiotensin receptor- 





of studies suggested that the MAPK activation assisted by beta-arrestin2 are crucial, 
while some other papers inferred that the beta-arrestins can regulate a bunch of 
cytoskeleton proteins like LIMK, filamin, and cofilin to reorganize the actin or 
microtubule. Despite of many pieces of information strongly supporting beta-arrestins’ 
importance in chemotaxis, yet, at cell biology level, the big picture that how beta-
arrestin2 help cell to detect and amplify the external gradient remains unclear. 
 
1.4 Organization of my thesis 
My thesis will aim to investigate two major aspects in chemotaxis. First, we will 
discuss how perfect adaptation is achieved via different mechanisms, i.e. why some cells 
use negative feedback as chemotaxis motif but other cells use incoherent feed-forward 
loop. In chapter3, we will suggest how these important and pressing challenges can be 
addressed in the context of eukaryotic cell polarity and migration, highlighting insights 
that begin to emerge as a result of promising developments in this area. 
Second, we will address the mechanism issues about beta-arrestin2-mediated 
imperfect adaptation in chemotaxis. How does beta-arrestin2 prompt chemotaxis without 
perfect adaptation? With this question in mind, we carried extensive survey of beta-
arrestin2’s function in chemotaxis. We will present our results and answer the question in 





Before stating the result in Chapter 3 and Chapter 4, we are going to describe out 
























2.1 The microfluidic chip design and fabrication 
In order to study cell chemotaxis in situ, we have to build an environment of 
uniform, repeatable and stable chemical gradients which can be applied to the cell. In the 
meanwhile, we should be able to observe the signaling events and cell behaviors with 
gradients applied. Traditional gradient generating devices like Boyden chamber, 
Zigmond Chamber, Dunn chamber, agarose assay, and micro-pipet either lack the ability 
to do live-cell imaging or can not generate stable and consistent chemical gradient. 
Microfluidic chips became the only choice [28-30]. Beyond the essential needs stated 
above, this novel technology offers several extra advantages: high through-put, small 
reagents consumption, dynamical controllability, customizability and extremely long 





Basically, two types of microfluidic chips are well designed to generate chemical 
gradients: Christmas tree and H-chip. The Christmas tree chip is popular for fast gradient 
generation (minutes) and flexibility in gradient shape, but has the cons that cells in the 
chip usually suffer from the shear stress of flow and the gradient goes unstable after 
hours of running. On the other side, the H-chip is slower in gradient generation (take 
about half hour to build up the gradient) and mostly restricted to linear gradient, but has 
the pros like no flow shear stress and gradients stable for days. The comparison of all 
these features made us to use the H-chip for our studies. 
 
 
Figure 2. 1 The Microfluidic chip we used for cell chemotaxis experiments. Food colors are 
used to show the flow of each channel. The real flows come from the inlets on the 
top, flow out through the outlets at the bottom. This chip has two experimental 
units in parallel: left two channels form one, the right two form the other one. In 





migration chamber. The flows in two channels will diffuse cross the gradient 
chamber and be applied to the cells seeded there [31]. 
 
The design of our chip showed in fig above. We used the food color to show the 
generated gradients. Four major design features are highlighted: 1. we designed three 
different cross channel lengths so that we can have 3 different steepness of gradients at 
the same time; 2. we fabricated the gradient chambers as 11~13 microns to simplify the 
cell-seeding process; 3. The ratio of heights between the flow chamber and gradient 
chambers are set to  >10 to maintain the gradient stability; 4. In each chip, we introduced 
two parallel experiments side-by-side as showed in Figure 2.1. This scheme allows us to 
have control or compare two conditiosn in the same experiment which increase the 
reliability of data. 
 
2.2 Plasmids and Cell lines 
The Rat Type 1A Angiotensin II receptor (AT1aR) with monomeric-CFP cloned 
in pcDNA3.1 and Rat beta-Arrestin2 with monomeric-YFP cloned in pcDNA3.1zeo were 
gifts from Dr. Lefkowitz. Beta-Tubulin with mCherry was a gift from Dr. Zhang. Beta-
Actin with mCherry was shared by Dr. Kim. The following are obtained from Addgene: 
cytoplasmic EKAR-Cerulean-Venus (No. 18679), Rab11-WT-dsRed (No. 12678), and 





fluorescence protein to make the AT1aR-mCherry construct in order to be compatible 
with other fluorescence markers.  
Fugene 6 and Fugene HD are used to transfect the cells. The rat vascular smooth 
muscle cell line is purchased from ATCC. The HEK293 cell line is obtained from Dr. 
Yarema.  
In our experiments, the results are very sensitive to the protein expression level of 
exogenous genes. In order to reduce the cell-to-cell variation, we decided to pick clonal 
cell lines after plasmid transfection. We created the following cell lines for our study: 
 
Figure 2. 2  Cell lines created for our study. The colors indicated the fluorescence protein 
fused to the gene of interest. The arrow indicates the derivation relationship. 






The HEK cell do not express AT1aR endogenously. We transfected the cells with 
AT1aR-mCFP to create the cell line with the receptor only. After picking a clonal cell 
line, we started to manipulate the beta-arrestin2 level. Since beta-arrestin2 is ubiquitous 
expressed, we used shRNA (Sigma) to knockdown endogenous the beta-arrestin2 level. 
To increase the expression level of beta-arrestin2, we transfected the receptor-only cell 
line with beta-arrestin2-mYFP, then picked 3 different YFP fluorescence intensity 
visually. The total expression level of beta-arrestin2 for 5 cell lines (knockdown, native, 
and 3 overexpressed) are confirmed by western blots.   
 
 
Figure 2. 3 Cell lines with various beta-arrestin2 expression levels are quantified by 






2.3 Antibodies and Reagents 
The anti- phos-ERK, beta-Arrestin2, and phos-p90RSK antibodies were 
purchased from Cell Signaling. The anti-alpha-Tubulin is from Abcam. Alexa Fluor 488-
conjugated goat anti-rabbit and Alexa Fluor 595-conjugated goat anti-mouse antibodies 
are from Life Technology. 
AngiotensinII (Ang) ligand was obtained from Sigma, AngiotensinII analog – 
[Sar1, Ile4, Ile8]-Angiotensin II (SII-Ang) was custom-synthesized at Cleveland Clinic 
Protein Core Facility (Cleveland, OH). 
 
2.4 Image acquisition and Data processing 
Images ware acquired on a Zeiss Aviovert 200M microscope with moving stage, 
isothermal incubator and CCD camera controlled by Slickbook 4.2.  The cell migrations 
were observed under 10x air objective. The fluorescence and FRET images were taken at 
40x oil objective with numerical aperture of 1.4. CFP was detected through a 436/20 
excitation filter, a 455 dichroic longpass mirror and 480/30 emission filter. YFP was 
detected through a 500/20 excitation filter, a 515ichroic longpass mirror and 525/30 
emission filter. FRET is detected through a 436/20 excitation filter, a 455 dichroic 
longpass mirror and 525/30 emission filter. To quantify the FRET signal, we used the 





           
                          
         
 
as proposed by Tadross [32] and Berney [33]. And the mCherry and RFP were detected 
through a 545/30 excitation filter, a 570dichroic longpass mirror and 610/75 emission 
filter. 
Images processing and data analysis were performed using Matlab R2010a 
(MathWorks). Field illumination correction, background subtraction, image 
segmentation, FRET ratio calculation and fluorescence quantification were performed 
according to the lab generalized protocol [34]. 
 
2.5 Cell Culture and Chemotaxis 
Cells were cultured at high-glucose DMEM (Life Technology) with 10% heat-
inactived FBS (Life Technology) added. To maintain the exogenous gene expression, 
400ug/ml G418 (Sigma), 100ug/ml Zeocin (Life Technology), 50ug/ml Hygromycin 
(Sigma), or 8ug/ml puromycin (Sigma) was added to the medium for certain cell lines. 
Microfluidic chips were coated with 10ug/ml human Fibronectin (Sigma) 
overnight at 4 ºC, washed with DPBS (Life Technology), filled with cell culture medium 
as above without antibiotics. Cells were seeded 6-8 hours before imaging. Right before 
the experiment, the ligands (or drugs) were perfused by being diluted in imaging 





HEPES (Sigma) +5mM MOPS (Sigma) + 0.2% BSA (Sigma), and replaced the cell 
culture medium. 
 
2.6 Western Blot 
Cell were pelleted and lysed by RIPA buffer (Thermo Scientific) with Halt 
protease and phosphatase inhibitor added (Thermo Scientific).  Equal micrograms of 
cellular extracts were separated on 10% TGX mini-precast gels and then transferred to 
0.22um nitrocellulose membranes. Washed membranes were blocked by 5% non-fat dry 
milk (non-phospho-protein detection) or BSA (phospho-protein detection) for 2 hours at 
room temperature (RT), and then incubated in primary antibodies with recommended 
dilution overnight at 4 ºC. Infrared-labeled secondary antibodies were applied for 2 hour 
incubation at RT after. LICOR scanner was used for imaging the western blot. 
 
2.7 Immunocytochemisty 
Cells were seeded at 30% confluence onto 20mm diameter circular coverslips 
(Fisher Scientific) coated with mixture of 0.1% poly_l_lysine (Sigma) and 0.1% gelatin 
(Sigma) and placed in a well of a 6-well tissue culture plate, then serum starved in 






After exposure to Ang for desired concentration and duration, the cells were 
washed three times with ice-cold DPBS (Life Technology). 4% paraformaldehyde 
(Electron Microscopy Sciences) was applied to fix the cells for 30 minutes. The cells 
were then permeabilized and blocked in blocking buffer contains 0.1% Triton X-100 
(Sigma) and 10% goat serum (Life Technology) in DPBS for 1 hour. Primary antibody 
incubation was done by incubating the cell with mouse anti-phospho-ERK1/2 (1:200 
dilution) or rabbit anti-phospho-p90RSK (1:200 dilution) in blocking buffer for 2 hours. 
Next, the cells were incubated in secondary antibody solution consisting of Alexa Fluor 
488-conjugated goat anti-rabbit (1:200 dilution) and/or Alexa Fluor 594-conjugated goat 
anti-mouse antibodies (1:200 dilution), 2ug/ml Hoechst-33258 (Sigma) for 2 hours. 
Finally, the stained coverslips were mounted on microscope glass slides and imaged. 
Cells were thoroughly washed with DBPS between each step. 
2.8 Computation and simulations 
The ordinary differential equations were setup in Matlab or Mathmatica 
(Wolfram). The time-lapse results were solved by ode45 or ode15a solvers in Matlab. 
The steady-state results were obtained in Mathematica. Parameter spaces were explored 









Adaptive molecular networks 
controlling chemotactic migration: 
dynamic inputs and selection of the 
network architecture 
 
3.1 Adaptation to spatially homogeneous stimuli: why and 
how? 
Perfect adaptation to step-like increases in the chemoattractant concentration has 
been observed both in bacterial and eukaryotic chemotactic signaling networks [36-38]. It 
has been argued that the ability to perfectly adapt to persistent ligand stimulation can 
provide a signaling system with many important advantages, including but not limited to 
the ability to extend the range of chemoattractant concentrations over which the gradient 





overall spatial extent of guided navigation, increasing the probability that a cell can 
successfully locate the source of the signal. 
Perfect adaptation of a signaling response turns out to be quite restrictive in terms 
of the number of possible ways it can achieved. A recent analysis suggested that the 
‘architecture’ or topology, of the underlying signaling networks would be expected to fall 
into two classes: those containing a negative (integral) feedback (NFB) and those that 
contain two parallel initially diverging and ultimately converging pathways, affecting the 
output in opposite ways. The latter network type has been termed an ‘incoherent feed-
forward’ loop (iFFL) [42]. The basic topologies of the two types of networks are showed 
as in Figure 3.1:  
 
Figure 3. 1 Structural comparison of the incoherent feed-forward loop and the negative 
feedback networks. The two types of networks that can achieve perfect 
adaptations. Upon ligand (L) stimulation, signal is transduced through an 
activating (A) and a delayed inhibitory (I) pathway to the response (R) node for 
the iFFL network; by contrast, the signal directly affects the response node 






We built the mathematical model based on the above structure. The ordinary 
differential equations (ODE) for the iFFL model are: 
  
  
                     
  
  
                     
  
  
                               
The ODEs of NFB model are: 
   
  
 
                  
           
 
          





              
          
 
        
        
 


























Table 3. 1 Parameters and conditions for simulation 
 
For the purpose of direct comparison, we modified the parameter of NFB model 
to fit its curve peak and time to the iFFL curve as showed in Figure 3.2. This helped us to 






Figure 3. 2 We modified the parameter to fit the time courses of NFB and iFFL curve: when 
the time to peak and the peak amplitude are matched in the models of iFFL and 
NFB, both models display perfect adaptation to a step input, with longer 
adaptation for iFFL 
 
It is of interest, and as suggested below, of possible importance, that the current 
biochemically informed models of bacterial chemotaxis postulate a type of negative 
feedback that carries information about a time integral of the input [6]. On the other hand, 
the prevailing model of an adaptive chemotactic signaling network, particularly in the 
archetypal examples of eukaryotic chemotactic motility of the amoebae cells of 
Dictyostelium discoideum and mammalian neutrophils, postulates an underlying iFFL 





iFFL model in eukaryotic cells has been under continuous debate, in part because the 
molecular components constituting the feed-forward loop are still not established with 
certainty [48]. However, recent analysis has argued particularly convincingly that iFFL is 
indeed the main driving molecular network type underlying both the perfectly adaptive 
response to spatially homogeneous changes in chemotactic stimuli and persistent non-
adaptive signaling in the presence of spatially graded distributions of the same stimuli 
[49, 50]. The experiments used to provide this evidence relied on exposing cells to 
dynamic stimuli more complex than a simple step-like increase in the stimulant 
concentration, with the temporal complexity of the inputs used in particular not only to 
argue  in  favor of iFFL model, but also against NFB models. 
 
3.2 Deciding between two mechanisms of perfect 
adaptation 
What signaling inputs can help to distinguish between two possible different 
network architectures, both of which can account for adaptive behavior, particularly if the 
molecular components of these networks are not precisely established? A popular test of 
network connectivity widely used in engineering and, more recently, in biology is to 






Figure 3. 3 We applied oscillatory input to both models. Both of them showed periodic 
response.   
 
Measurement of the  signaling outputs when the frequency of the input is varied 
can reveal inherent filtering capabilities of the molecular circuit, so that the response is 
maximized at high (‘high-pass filter’), low (‘low-pass filter’) or intermediate (‘band-pass 
filter’) input frequency. In the case of yeast osmoregulation, the signaling pathway 
mediation  of cell adaptation to high osmolarity has been shown to have band-pass 
filtering properties, the property that was used to infer the existence behind a negative 
feedback network structure. Unfortunately, although band-pass filtering requires 
considerable network complexity, both negative feedback and iFFL circuits can be 






Figure 3. 4 Both models showed band-pass filter behavior 
 
Indeed, if simple NFB and iFFL models are matched in such a way that the 
adaptation to a step input yields identical timing and amplitude of the transient response 
(‘matched iFFL and NFB models’), their responses to various dynamic stimuli [58] can 
be meaningfully contrasted (figures 3.4, 3.5 and 3.6). If such matched iFFL and NFB 
models are subjected to oscillatory stimuli, both show essentially indistinguishable 
dynamic response characteristics and qualitatively similar band-pass responses (figure 
3.4). Thus, even though a recent analysis has demonstrated that the network underlying 
adaptation in D. discoideum chemotaxis has band-pass filtering characteristics [49], this 
fact could not be used to determine whether the adaptive response relied on iFFL or on 






Figure 3. 5 The two networks behave similar at stepped stimuli input in a), both b) iFFL 






Figure 3. 6 The two networks behave similar at fold-change stimuli input in a), both b) iFFL 







What might be the input that discriminates between the underlying iFFL and NFB 
architectures? It turns out that ‘ramp’ inputs, i.e. the inputs that persistently increase with 
constant rates, can be such discriminating dynamical test inputs. Indeed, as can be easily 
seen from stimulation of the matched iFFL and NFB networks (Figure 3.7), and shown 
on more theoretical grounds, the NFB does not adapt perfectly to ramp stimulation, 
instead, coming to a steady-state activity proportional to the slope of the ramp [49]. In 
this sense, its output is proportional to the time derivative of the input, with the NFB 
serving as the ‘differentiator’. On the other hand, the iFFL can perfectly adapt to the 
ramp stimuli, with the transient response but not the steady-state behavior affected by the 
slope of the ramp. This test, when applied to the D. discoideum chemotactic signaling 
network, strongly suggested that it indeed has the embedded iFFL but not NFB structure. 
However, when applied to the high osmolarity response pathway in yeast or in bacterial 







Figure 3. 7 The ramp inputs in a) can distinguish the two network architectures: b) iFFL 
and c) NFB. NFB can not adapt to ramp inputs, but is a good choice for 






3.3 Can there be different selective pressure for evolution 
of different adaptation mechanisms? 
Mounting evidence suggesting that adaptive molecular networks responsible for 
chemotactic responses can rely on both iFFL and NFB architectures begs the question of 
whether this evolutionary choice is biased by the demands of the chemotactic response 
itself for different organisms or whether it is more random. Where can the selective 
pressure stem from? As shown above, the key difference in dynamic responses between 
these network types can lie in their response to the dynamically complex stimuli, in 
particular, ramp inputs. Can this difference also suggest why these networks can present 
unique advantages in the real-world chemotactic behavior? This is an important 
consideration, in part because laboratory analysis is frequently designed to present cells 
with simplified inputs versus those faced by the cells in more natural situations. 
Fortunately, for both bacterial chemotaxis and the chemotaxis of the amoebae D. 
discoideum, much is known about their natural environmental inputs, thus permitting the 
analysis of what the relevant input distribution is and what the cells might in fact respond 
to incoherent feed-forward loop or negative feedback.  
The key difference between bacterial chemotaxis and chemotactic responses by 
eukaryotic cells, including D. discoideum, is that bacterial cells, given their small size, 
have to actively explore  the  chemotactic  fields  by actively  moving  within them,  
whereas  the  eukaryotic  cells  are  large  enough  to reliably measure the difference 





bacterial cells effectively measure the spatial gradients of chemoattractant by exploring 
them in time, sampling concentrations as they actively navigate through them during their 
own locomotion. Thus, the measurement that the cells rely on is the measurement of the 
rate of change of the chemotactic input, corresponding to the ramp stimulation discussed 
above. As the rate of the change increases, the cells would tend to maximize their 
response, recognizing that they move in the direction leading them more precisely 
towards the source of the chemoattractant. As suggested above, NFB circuits are 
perfectly suited for this type of computation, with the steady-state response proportional 
to the slope of the ramp stimulus (a complication here can arise from the properties of the 
receptors involved in bacterial chemotaxis, so that in fact exponential rather than linear 
ligand ramps need to be delivered to ensure linear ramp input into the NFB signaling 
network downstream of the receptor [60-62]). The situation in the natural D. discoideum 
responses is more complex. During the developmental response, individual cells 
assemble into a multicellular organism by virtue of both secreting and responding to a 
chemoattractant, presenting in the form of self-sustained waves propagating through the 
cell community. Therefore, individual cells are exposed to a complex input presenting 
them with crests and troughs of chemoattractant concentration, and gradients that can 
change their sign (direction) as the crest (trough) of the wave passes over a cell. Although 
a cell can measure the gradient without moving or while moving relatively slowly, the 
conflicting cues have the potential to force its movement both towards and against the 
direction towards the source of the chemoattractant. Therefore, it can be hard to make 
progress; yet individual cells appear to solve this problem well. This fact strongly 





crest) but not the other (crest to trough) of each incoming wave. Furthermore, the cells 
can maximize the response if the fact that the average concentration changes during the 
passage of each wave does not interfere with their spatial gradient measurement. Hence, 
adaptation to temporally changing input can be a key in this response, necessitating the 
iFFL but not the NFB architecture. 
These considerations, although still largely speculative, strongly suggest that the 
complexity of the environmental inputs faced by individual chemotactic organisms as 
well as the internal limitations inherent in these organisms (e.g. the size of a cell 
undergoing chemotaxis) can impose important constraints in selection of one of the 
available adaptive network architectures. This observation is linked to a more general 
question often ignored in the analysis of signaling networks which aspect of the input do 
cells really ‘care about’?  More precisely put, which aspect of the input contains the most 
information relevant to the cell decision- making? [63, 64] The information about spatial 
gradients can be contained both in space and in time, and individual networks may evolve 
to respond to one of this information sources while ignoring the other. 
Another important aspect of functioning of different molecular networks is their 
noisy nature. Indeed, chemical reactions can be subject to considerable fluctuation in 
concentration and thus rates of various reactions. Again it may be instructive to determine 
whether the ability of iFFL and NFB circuits to withstand such fluctuations may be 
similar. Simulation results for the matched models (Figure 3.8 and 3.9) suggest that the 
NFB can robustly ensure constant duration of the output to the step increase in the 
chemoattractant input (the duration of the transient peak) but not the amplitude of the 






Figure 3. 8 Comparison of iFFL and NFB model outputs under noisy parameter sets. 
Variation of parameter values by 10% introduces variability of responses to step 
inputs for the matched iFFL (red, a) and NFB (blue, b). The inserts are 





of the amplitude of the peak responses suggests the possibility for a 
substantial reduction of variability in all responses, but in particular in 
the response of the iFFL model to the step input. 
 
On the other hand, the response of the iFFL model is much more variable in terms 
of the peak duration, since, in this response, the amplitude is linked more tightly to the 
duration of the peak. This result may suggest lower robustness of the iFFL circuit to the 
‘noise’ or small variations in the  activity of the signaling pathways. However, the tight 
coordination between the amplitude of the peak and its duration also implies that 
correcting for variability in either amplitude or duration can also decrease the overall 
variability of the response (Figure 3.8 and 3.9), making iFFL more robust to noise than 
NFB. This property of the iFFL circuit can be connected to the so-called ‘fold- response’ 
capacity, i.e. the ability of the sensory system to robustly measure fold-changes in 
response, while being less sensitive to either average value of the  input or the  less 
substantial input changes. This property may in turn relate to inherent ability of iFFL to 
adapt to linear ramp inputs, as discussed earlier, suggesting that nonlinear inputs 
characterizing fold responses can be more effective in eliciting sustained responses. The 
consequences of this property for gradient sensing capabilities of D. discoideum and 






Figure 3. 9 Comparison of iFFL and NFB model outputs under noisy parameter sets. 
Variation of parameter values by 10% introduces variability of responses to 
ramp inputs for the matched iFFL (red, a) and NFB (blue, b). The inserts are 






3.4 Analysis of other signaling networks with 
incompletely known chemical composition and 
organization 
Understanding the structure of signaling networks is paramount for investigation 
of their dynamical behavior and function. However, frequently, the molecular 
components of these networks and their inter-molecular interactions may not be 
completely known or easily assayed using classical tools of genetics and molecular 
biology. As illustrated earlier, the ability to expose live cells to tightly controlled 
dynamically complex stimuli can help distinguish between alternative models that can 
account for observed signaling responses. This analysis involves a combination of 
mathematical analysis and matched quantitative experimentation, which together can help 
unravel the functional characteristics of the signaling apparatus. Importantly, this analysis 
can also be suggestive of the nature of the environmental inputs processed by the 
networks. The fact that the natural, in vivo signaling fields are known for at least some 
chemotactic responses, along with the knowledge of limitations on the sensory 
capabilities of chemotactic cells, has been used above to justify the use of alternative 
sensing strategies. However, for many other signaling networks, the dynamics and spatial 
distribution of signaling inputs are frequently unknown. Controlled presentation of large 
sets of distinct, dynamically complex stimuli can allow one to determine which aspects of 
the input can be sensed best and which stimuli can trigger qualitatively distinct outputs. 





signaling networks, and the analysis of how evolutionary selection of a particular 
network type might have taken place. Signaling networks underlying cell polarization and 
chemotactic migration can thus serve as important and influential archetypes for the new 




















Scaffold proteins can both facilitate or inhibit signaling processes in a 
concentration-dependent manner [65]. This dual function can be achieved since scaffolds 
expressed at low or optimal levels can enforce juxtaposition of interacting molecular 
species, whereas scaffold over-expression can titrate these molecular species away from 
each other. This dose dependence suggests that uneven spatial distribution of scaffold 
molecules within a cell can result in a spatially inhomogeneous signaling outcome, which 
in turn might lead to polarization of cellular functions regulated by the signaling. If these 
functions are associated with re-organization of cellular cytoskeleton, oriented cell 
growth or migration may ensue. Indeed, within the context of the yeast mating response, 
inhomogeneous distribution of a scaffold protein within a cell responding to a pheromone 
gradient can result in a spatially graded distribution of the associated MAPK signaling 
[66]. Furthermore, global variation of the scaffold levels within the same signaling 
system has the predicted biphasic effect on the downstream gene regulation [67]. 
However, it is not clear whether the scaffold-mediated gradient of MAPK activity in the 





Furthermore, in spite of these suggestive findings in budding yeast, the existence of 
similar cell polarization mechanisms and their possible relationship to directed migration 
response in other cell types, e.g., in mammalian migratory cells, remains unclear.  
beta-arrestin2 is a ubiquitous mammalian scaffold molecule implicated in the 
control of chemotactic responses. Subsequent research also implicated these proteins in 
classical scaffolding functions, by demonstrating their association with and regulation of 
multiple signaling pathways [68]. Furthermore, a recent study demonstrated that beta-
arrestin-2 function is essential for directed migration of HEK293 cells expressing 
Angiotensin II (AngII) receptor (AT1aR) in sharp gradients of AngII [25]. This result 
however, left open multiple questions about the putative beta-arresin2 role in control of 
chemotaxis. Does it enforce chemotaxis, by promoting polarization of signaling and 
cytoskeletal components as proposed above, or is its role in regulation of chemotaxis 
purely permissive? Is the signaling pathway scaffolding or receptor internalization 
function of beta-arrestin2 primary in this response? Moreover, it is unclear if the 
distribution of beta-arrestin2 within the cells exposed to AngII gradients is spatially 
inhomogeneous, and if so, whether the polarization of the signaling can be compromised 
in very shallow AngII concentration gradients. Answering these questions may reveal a 
previously unappreciated, new mechanism of cell polarization and chemotactic response.   
In this study, using a combination of diverse experimental techniques and 
computational modeling, we set out to ascertain the importance of beta-arrestin2 in 
chemotactic regulation and to investigate the underlying mechanisms. We found that the 
control of chemotactic behavior by beta-arrestin2 depends on its ability to serve as a 





surprisingly, that both receptor internalization and signal scaffolding functions of beta-
arrestin2 are critically important for effective chemotaxis. Trafficking of internalized 
receptor complexes is essential for amplification of shallow input gradients, whose 
direction was decoded by signaling through the ERK pathway. Overexpression of beta-
arrestin-2 leads to dramatic changes in cell migration behavior, including conversion 
from chemo-attraction to chemo-repulsion. Overall, the interplay between the scaffold 
expression, input dose, and intracellular trafficking is found to be critical in defining this 




Beta-arrestin is necessary in chemotaxis 
 
The initial evidence for the importance of beta-arrestin2 in chemotactic response 
to AngII gradients was obtained from trans-well experiments [25]. However, these assays 
did not always have unambiguous interpretation, as the results may depend on both 
migratory and invasive cell behavior. We therefore first validated AngII-mediated 
chemotactic behavior by direct monitoring of live cell migration within a microfluidic 
device, which design allowed the analysis of cell responses to diffusion-based gradients 
[31]. We indeed found that HEK293 cells with exogenously expressed AT1aR displayed 






Figure 4. 1 HEK cells expressing Angiotensin receptor are chemotactic to angiotensin II 






We also observed that A7r5 rat vascular smooth muscle cells endogenously 
expressing AT1aR displayed a strong chemotactic response to AngII, supporting its 
function as an effective natural chemoattractant, and consistent with prior results [69] 
(Figure 4.2).  
 
Figure 4. 2 Vascular smooth muscle cell shows chemotaxis behavior in our microfluidic 
devices. * denote p<0.01. Error bars denote the standard error of mean. 
 
Increasing the value of the AngII gradient led to stronger chemotactic attraction of 
HEK293 cells, the response that was further amplified when the levels of beta-arresin2 






Figure 4. 3 Cells response to different gradients. Moderately expressed beta-arrestin2 
increases the cell sensitivity to external gradient. * denote p<0.01. Error bars 
denote the standard error of mean. 
 
We also confirmed that shRNA mediated silencing of beta-arrestin2 expression 
severely suppressed chemotaxis (Figure 4.4), and that chemotaxis could occur in the 






Figure 4. 4 Knockdown of beta-arrestin2 will reduces the cell chemotactic response. * 








Figure 4. 5 Angiotensin analog, SII, which only activates the beta-arrestin2-dependent 
pathway without triggering the G-protein depend pathway, enhances the cell 
chemotactic behavior. * denote p<0.01. Error bars denote the standard error of 
mean. 
 
Furthermore, we observed that chemotactic response to SII was surprisingly 
stronger than chemotaxis to AngII, as evidenced by the normalization of the results to 
account for different receptor affinity of these two compounds. These findings suggested 







What other molecules are involved in beta-arrestin2 mediated 
chemotaxis 
 
How does beta-arrestin2-mediated signaling control the chemotactic response? To 
analyze the underlying molecular mechanisms in greater details, we first exposed the 
cells to spatially homogenous step-wise elevations of AngII concentration. We used 
several live cell probes to follow different stages of the AngII triggered signal 
propagation. We found that, at different AngII doses, beta-arrestin2 displayed transient 
translocation to the membrane, followed by persistent cytosolic localization (Figure 4.6) 






Figure 4. 6 Beta-arrestin2 is recruited to the membrane upon AngII stimulation (5 minute), 
then binds to receptor and forms internalized vesicle (30 minute). The plot 
showed the time course of beta-arrestin2 translocation to membrane. Shades 
denote the standard error of the mean while solid lines are the mean values. 
Blue is for high dose of AngII (30ng/ml) and orange is for low dose (1.6ng/ml). 







Figure 4. 7 Beta-arrestin2-receptor complex is displayed by FRET technology. The receptor 
is fused with CFP and beta-arresitn2 is fused with mYFP. When they approach 
each other (<10nm), the FRET happens. When cells just gets stimulated by 
AngII, the FRET is stronger at membrane which means the beta-arrestin2 is 
attached to the receptor. After vesicle formation, the vesicles are exhibiting 
higher FRET signal. Color bar shows the FRET strength.  Shades denote the 
standard error of the mean which solid lines are the mean values. Blue is for 
high dose of AngII (30ng/ml) and orange is for low dose (1.6ng/ml). Scale bar 
size: 5um. 
 
The complex formation was reported by the FRET signal between AT1aR and 
beta-arrestin2 [70]. Furthermore, prevention of endocytosis and resulting vesicle 





AT1aR-beta-arrestin2 complex was the functionally important form of beta-arrestin2 in 
chemotactic signaling (Figure 4.8). This result further suggested that the signaling species 
activated by this complex would be associated with internalized vesicles.  
 
Figure 4. 8 Endocytosis inhibitors inhibit the cell chemotaxis. Three different inhibitors 
were chosen and they block the receptor endocytosis by different mechanisms: 
Dynasor blocks the dynamin activity to stop the vesicle scissoring at membrane; 
Monesin blocks intracellular protein transport; MβCD disrupts lipid rafts by 
removing cholesterol from membranes. * denote p<0.01. Error bars denote the 






We found that ERK activity was upregulated contemporaneously with AT1aR-
beta-arrestin2 complex formation (Figure 4.9). The kinase activity underwent strong, 
dose-dependent activation followed by incomplete adaptation to the steady levels 
dependent on the AngII dose.  
 
Figure 4. 9 The ERK phosphorylation activities are displayed by FRET probe EKAR. The 
ERK phosphorylation starts right after cell stimulation by AngII, reaches its 
peak at after 5~10 minutes then decreases. But after a long term, it still does not 
achieve full adaptation. Color bar is showing the FRET strength.  Shades denote 
the standard error of the mean while solid lines are the mean values. Blue is for 






ERK is a direct and important downstream signaling molecule. Whether it is 
involved in beta-arrestin2 mediated chemotaxis is still controversial [71]. But our device 
can easily test this ambiguity in our system. Indeed, we found ERK signaling is crucial to 
the AngII stimulated cell chemotaxis, since upon the inhibition of ERK pathway by 
U0126,   the cell chemotaxis will be dramatically suppressed (Figure 4.10).  
 
 
Figure 4. 10 U0126, a specific ERK pathway inhibitor, can reduce the cell AngII induced 






When averaged time-dependent responses of the distinct signaling species 
analyzed above were normalized to the time of AngII addition and overlaid on the same 
graph, it became clear that ERK activation closely follows the kinetics of AT1aR-beta-
arrestin complex formation, prior to its partial adaptation (Figure 4.11). 
 
 






 Regulation of beta-arrestin2 by actin 
Addition of AngII also triggered strong and transient translocation of actin to the 
plasma membrane (Figure 4.12) and associated expansion of the membrane, in an AngII 
dose-dependent manner.  
 
Figure 4. 12 Actin translocation to the plasma membrane starts when AngII is applied to 
the cells. Actin facilitates vesicle forming and receptor internalization, moves 
away after vesicle forming. Shades denote the standard error of the mean which 
solid lines are the mean values. Blue is for high dose of AngII (30ng/ml) and 






 The kinetics of actin response was hypersensitive to the AngII addition, 
exhibiting both rapid activation and rapid adaptation. Overexpression of actin within the 
cells led to an increased stress fiber formation and cell spreading. In such cells, the higher 
surface to volume ratio results in, on average, a shorter distance required for translocation 
of beta-arrestin2 to the plasma membrane, thus suggesting more rapid translocation 
kinetics, which was indeed experimentally confirmed (Figure 4.13). Faster scaffold 
recruitment dynamics was associated closely with a faster translocation of actin to the 
plasma membrane, further supporting the causative link between beta-arrestin2 activation 
and actin-based morphology change. In summary, these results suggested that AngII 
triggers a sequence of signaling events ultimately leading to both dose dependent Erk1/2 
activation and actin-dependent morphological change, with both outcomes potentially 







Figure 4. 13 Actin overexpression induces faster beta-arrestin2 dynamics, both the 
translocation to membrane and endocytosis. 
 
Scaffold effect of beta-arrestin2 in chemotaxis 
Since beta-arrestin can regulate signaling events by both controlling receptor 
internalization and directly scaffolding signaling pathways, beta-arrestin2 overexpression 
can potentially affect signaling outcome through either or both of these processes. We 
thus explored, at several distinct doses of AngII, whether beta-arrestin-2 expression in 
amounts leading to strong impairment of cell migration directionality would negatively 





of AngII, high scaffold levels dramatically decreased beta-arrestin2-enriched vesicle 
formation (Figure 4.14). Conversely, the intermediate levels of beta-arrestin2 expression 
led to an increase in vesicle formation, in an AngII-dose dependent fashion (Figure 4.14).  
 
 
Figure 4. 14 Beta-arrestin2 in vesicle is a non-linear function of receptor occupancy. When 
the beta-arrestin2 level is too high, the endocytosis mediated by beta-arrestin2 is 
actually decreased. 
 
ERK signaling was also negatively affected by high levels of beta-arrestin2 
expression. However, it displayed a more complex dependence on the AngII dose (Figure 
4.15). For both beta-arrestin2 levels analyzed, the ERK dose dependencies were biphasic, 





cellular responses called for development of a computational model capable of 
interpretating for the experimental results obtained so far, and of predicting cell behaviors 
under different circumstances, particularly under the AngII gradient stimulation.  
 
 
Figure 4. 15 The ERK phosphorylation detected by immunocytochemistry. They showed 
standard scaffold-dependent biophasical curve. High level of the beta-arrestin2 
scaffold decreased ERK activation. Error bars denote the standard error of the 
mean. 
 






The model illustrated in the schematic (Figure 4.16) was based on the assumption 
that beta-arrestin-2 can control the signaling outputs by biphasically affecting both 
receptor internalization at the plasma membrane and ERK activation in the vesicles. This 
type of biphasic dependence on molecular concentration is expected of any cross-linker 
molecule, including adapter and scaffold proteins [72]. Furthermore, it was assumed that 
ERK activity could display a degree of scaffold-independent activity in the cytosol. The 
resulting model was partially based on our prior model of the scaffold-mediated MAPK 
signaling, with the important modification to account for several cellular compartments: 
plasma membrane, cytosol, and vesicles. The model, after parameter adjustment, could 
successfully account for several experimental datasets described above. We next 
extended the model by introducing spatial dimensionality into simulations and attempting 
to predict cell responses to gradients of AngII. Although the model could account for 
some degree of cell polarization, the differences between the signaling activities in the 
rear and front portions of the cell tended to be very weak in shallow AngII gradients (data 
not shown). This suggested that an amplification mechanism may be present in the 
signaling network such that shallow ligand gradients are transduced into stronger 
polarized intracellular signaling responses. We next examined this prediction and 







Figure 4. 16 The basic model for calculating cell chemotactic index. ERK activity is 
biphasicly mapped on the beta-arrestin2 concentration. The cell chemotaxis 
index is the difference of ERK activity at cell front and back. 
 
When examined in AngII gradients, the intracellular distributions of internalized 
receptor, beta-arrestin2 and ERK activities displayed strong asymmetry, which exceeded 







Figure 4. 17 A) The receptor, beta-arrestin2, receptor-arrestin2 association in vesicles and 
pERK distributions are prominently polarized toward the upstream of gradient. 





polarization inside cells. The values are all normalized to the external gradient. 
Error bars denote standard error of the mean. Scale bars represent 10um. 
 
This result suggested the existence of a mechanism to amplify the difference 
between the signaling activities in the front and the rear of the cells. Since beta-arrestin2 
localization and ERK activity were confined to the vesicles, one immediate possibility for 
an amplification mechanism was that not only vesicle formation (through internalization) 
was affected by the asymmetry of the input, but also vesicle recycling, with the gradient 
of recycling being opposite to that of the gradient of internalization. To test this idea we 
first noted that vesicle trafficking, but not vesicle formation, was microtubule-dependent 







Figure 4. 18 Inhibition of the microtubule polymerization prevented vesicle merge and 
formed many dangling small vesicles. 
 
Inhibition of microtubules with Nocodazole, a microtubule disrupting agent, also 
progressively reduced amplification of beta-arrestin2 polarization in the AngII gradients 
(Figure 4.19). This result not only confirmed potential role of microtubule-based vesicle 
trafficking in gradient amplification, but raised the question of whether this process could 







Figure 4. 19 Inhibiting microtubule polymerization induced the suppression on the beta-
arrestin2 polarization in cells under gradient. Error bars denote the standard 
error of the mean. 
 
Previously, it has been determined that a small GTP-ase Rab11 could control 
endosome recycling in a microtubule dependent fashion [73]. Furthermore, Rab11 has 
been associated with various forms of in vivo cell migration [73-75]. We found that, in 
cells exposed to AngII gradients, Rab11 translocated to the back of the cell, consistent 
with possible AngII gradient induced polarization of vesicle recycling (Figure 4.17). 





loss of signal amplification and biased cell migration, further supporting its functionality 
in gradient sensing (Figure 4.20). We thus modified the model to account for asymmetric 
vesicle formation and recycling occurring in the beta-arrestin-2 and Rab11 manner 
(Figure 4.21), respectively.  
 
 
Figure 4. 20 Inhibion of Rab11 activity by overexpressing its dominant negative mutation 
drastically annihilated the cell chemotaxis. * denote p<0.01. Error bars denote 







Figure 4. 21 A more sophisticated model account that vesicle endocytosis and recycling are 
also biphasicly dependent on the beta-arrestin2 scaffold level.  
 
 
Models can predict the co-existence of chemoattractance and 
chemorepulsion. 
The model made several important predictions that we sought to validate 
experimentally. First, it predicted that, in line with beta-arrestin2 playing a role of a 
classical scaffold molecule, different levels of scaffold expression are expected to result 
in biphasic changes in both ERK activity and the corresponding bias in chemotactic 







Figure 4. 22 Model predicted that both the ERK phosphorylation and cell chemotaxis 
behavior will be biphasic as the function of beta-arrestin2 scaffold, and a lag 
phase is also expected. 
 
Furthermore, the optimal levels of the scaffold for these two responses were 
predicted to be shifted with respect to each other, so that chemotactic bias would peak at 
a lower scaffold level relative to the level of the scaffold optimizing ERK activation 
(Figure 4.22). This was indeed observed in the experiments, when clones expressing 







Figure 4. 23 A) Westernblot showed that ERK activation is biphasic when increasing the 
beta-arrestin2 scaffold expression level. B) Both the ERK phosphorylation and 





And The lag phase is appeared to be same as predicted in the mode. Error bars 
denote the standard error of the mean. 
The model also predicted (Figure 4.24) and experiments confirmed (Figure 4.25) 
that microtubule disruption by nocodazole can lead to a relative increase in the Erk1/2 
activity, due to accumulation of intracellular vesicles, which is also experimentally 
confirmed (Figure 4.25). 
 
 
Figure 4. 24 Model predicted that when the microtubule polymerization is inhibited, the 
accumulated vesicle will induce more ERK phosphorylation since the ERK 









Figure 4. 25 Experiments confirm that when microtubule polymerization is inhibited by 
Nocodazole, ERK activity is elevated. Error bars denote the standard error of 
mean. 
 
Variations of the scaffold levels and of the average local concentrations of AngII 
were predicted to lead to complex chemotactic responses. An important assumption here, 
stemming from the earlier experimental results, was that the vesicle formation was 
positively regulated by AngII levels, promoting beta-arrestin2 recruitment.  For the level 





experiments confirmed (Figure 4.27), that the AngII gradient would be interpreted by the 
cells to be chemo-attractive at all levels of local AngII, with a weak or no dependence on 
the AngII dose. On the other hand, for the highly overexpressed beta-arrestin2 levels, the 
model and experiment showed that cells can switch from chemo-attraction to chemo-
repulsion at the low AngII concentrations, and switch back to chemo-attraction at higher 
AngII levels.  
 
 
Figure 4. 26 Model predicts the co-existence of chemoattraction and chemorepulsion when 
the beta-arrestin2 scaffold is too high. The chemoattraction happened at high 
local AngII concentration and chemorepulsion is at low local AngII 









Figure 4. 27 Experiments confirmed the the co-existence of chemoattraction and 
chemorepulsion when the expression level of beta-arrestin2 scaffold is too high. 
However, when the scaffold level is moderate, the cell only showed 
chemoattraction phase which is only weakly depend on the local AngII 
concentration 
 
The explanation suggested by the model was that the repulsive response was due 
to the inhibition of ERK signaling at high scaffold levels in the vesicles, thus maximizing 
ERK signaling on the side of the cell exposed to lower rather than higher AngII inputs. 
On the other hand, the switch back to attraction was associated with an additional effect 
of decreased vesicle formation when scaffold and AngII input levels were both high, thus 
negating the effect of the scaffold-based suppression of ERK signaling from the vesicles 







Figure 4. 28 At optimal beta-arrestin2 scaffold level, the scaffold vesicle are more polarized 
towards the higher concentration of AngII. In contrast, the scaffold vesicle are 
more polarized towards the lower concentration of AngII at high beta-arrestin2 
scaffold level. 
 
The model therefore predicted that this ‘double negative’ effect of the scaffold 
over-expression at high AngII levels should be compensated by a greater vesicle 
retention, e.g., by inhibiting microtubule-mediated vesicle trafficking and recycling. 
Indeed, treatment of cells containing over-expressed beta-arrestin-2 with Nocodazole led 







Figure 4. 29 When the Nocodazole is applied to the high beta-arrestin2 scaffold expression 
cells, they showed chemorepulsion instead of chemoattraction in control 
experiments. .* denote p<0.01. Error bars denote the standard error of the 
mean. 
 
The model was also successful in predicting other properties of the cell migration 
response, including the dependence of the chemotactic bias on the gradient value (Figure 
4.30).  Overall, the consistency between the model and experiment strongly suggested 
that the model correctly captures the mechanism of the chemotactic response controlled 
by beta-arrestin2. Surprisingly, both the role of beta-arrestin2 in the scaffolding signaling 
species within the vesicles and its role in vesicles trafficking (along with the reciprocal 





gradients. The vesicle trafficking resulted in amplification of extracellular ligand 
asymmetry, which was then interpreted by the cells according to the combination of the 
input strength and scaffold expression, resulting in strongly asymmetric Erk activity, cell 
polarization, and directional migration.  
 
 
Figure 4. 30 Model predicts that the cells with different scaffold expression level have 
different gradient sensitivity. 
 
At last, again, we happened to find that the actin polymerization and beta-
arrestin2 vesicle happen to be colocalized during the cell chemotaxis (Figure 4.31). This 





mechanisms and found that the beta-arrestin2 locally scaffold the activation of pERK, 




Figure 4. 31 LifeAct is a probe to detect the actin polymerization in situ. The arrows 







Figure 4. 32 The p90RSK phosphorylation is colocalized with beta-arrestin2 vesicle when 











Conclusions and Perspectives 
 
5.1 Conclusions 
My dissertation has been focusing on the mechanistic studies of chemotaxis, with 
both experimental and computational approaches at the level of cell signaling pathways. 
In chapter 3, we systematically compared the two popular cell chemotaxis models in 
parallel: negative feedback (NFB) and incoherent feed-forward loop (iFFL). Our in silico 
experiments pointed out that none of the oscillatory, stepped, or fold-changed input can 
distinguish the two network topologies. The only input signal that can clearly partition 
between them is ramped-input, at which condition the NFB showed no adaptation while 
iFFL still robustly exhibited perfect adaptation. 
The two different chemotaxis frameworks are utilized by distinct organisms: 
bacteria use the NFB while eukaryotes prefer iFFL. More importantly, our simulations 
indicated that the different choices were resulted from evolution fitness rather than 
occasional development.   
When trying to determine which category the beta-arrestin2-mediated chemotaxis 





that our results suggested that beta-arrestin2-mediated activation of ERK can trigger 
chemo-attractive and chemo-repulsive responses to the gradients of AngII. This is in 
contradictory to many popular models of gradient sensing, including the so-called Local 
Excitation-Global Inhibition (LEGI) model (an extension of iFFL), proposed for 
chemotaxis of social amoebae cells or neutrophils, the models that cannot account for 
repulsive responses.  
In Chapter 4, we investigated the unconventional mechanism of beta-arrestin2-
mediated chemotaxis. The experimental results evidenced that the operation behind this 
chemotaxis is closely related to the scaffold property of beta-arrestin2. Scaffolding and 
trafficking of the components in signaling networks can exert important modifying 
effects on the activity and the ultimate functional outcome of the signaling event. In 
particular, local enrichment of the signaling complexes within the cell body can lead to a 
strong spatial polarization of the related intracellular processes. The local control of 
signaling is achieved by the dual functionality of beta-arrestin2: both as an agent 
promoting vesicle internalization and as a classical scaffold nucleating the signaling 
activity. As a result, the polarized signaling activity can amplify the gradient of the 
extracellular cue, particularly if balanced by reverse polarization of vesicle recycling. 
These results suggested that vesicle trafficking can have an effect on cell migration that 
adds to the commonly observed recycling of integrin receptors [77, 78], revealing a 








The biphasic dependence of the scaffold-mediated signaling response on the 
concentration of the scaffold proteins provides a convenient mechanism for the 
possibility of both guiding attractive and repulsive responses in chemotactic migration by 
the same cue. Since the presence of scaffolds is commonplace, particularly within the 
MAPK signaling cascades [44], various means of polarizing spatial scaffold distribution 
within a cell can provide a general means for polarized cell behavior in response to a 
variety of extracellular cues, including gradients of growth factors or cytokines. 
The mechanism of beta-arrestin2-mediated gradients sensing and chemotaxis 
suggested by our study also may shed additional light on an increasing number of cases 
strongly implicating Rab11 in directed single and collective cell migration [79]. Coupling 
of beta-arrestin, as a dual function protein affecting both receptor complex internalization 
and downstream signaling events, to the complementary recycling role of Rab11 can 
provide a powerful coupled mechanism regulating signaling events essential for orienting 
cell polarity and migration.  Although many details of the relevant Rab11 regulation 
processes remain to be elucidated, it will be of particular interest to examine whether in 
other migratory systems, the function of this small GTPase is also coupled to a 
counterpart protein network controlling receptor internalization and signaling, yielding a 
powerful cell polarity mechanism. 
The results presented here also highlight the diversity of possible mechanisms of 





the beta-arrestin2-mediated activation of the MAPK cascade can provide an alternative or 
a complement to the commonly observed role of PI3K signaling at the plasma membrane, 
which was thought be a critical component in many established chemotaxis models [80, 
81]. More generally, it will be of great interest to investigate if other mechanisms of 
achieving bi-phasic dose dependence of signaling responses might mediate chemotactic 
behavior, particularly, when the same molecules can drive both attractive and repulsive 
responses [82-84]. Such a mechanism, coupling complex dose responsiveness of 
signaling networks to non-uniform spatial distribution of signaling components, can 
dramatically increase the functionality of the resultant phenotypes and reveal the full 
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